laurus labs EMA cross over DAILY CHART
Laurus Labs (LAURUS)’s Annual Report Analysis indicates a sharp improvement in
ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating
profit, and a reduced interest rate, the brokerages have upgraded their target as well;
ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating
profit, and a reduced interest rate, the brokerages have upgraded their target as well;
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.